Literature DB >> 9927198

WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts.

S Hosono1, X Luo, D P Hyink, L M Schnapp, P D Wilson, C R Burrow, J C Reddy, G F Atweh, J D Licht.   

Abstract

The WT1 tumor suppressor gene, implicated in hereditofamilial and sporadic Wilms' tumor, is required for normal renal development and is up-regulated during the mesenchymal-epithelial transition. NIH3T3 fibroblasts overexpressing WT1 were less proliferative, larger in size and more firmly attached to tissue culture plastic, suggesting an alteration of their state of differentiation. These cells were studied in vivo by subcutaneous injection into nude mice. The resulting tumors exhibited epithelioid histopathology and formed desmosome-like structures. Molecular analyses of these WT1 expressing fibroblasts grown in culture and in nude mice revealed significant alterations in the expression of many kidney epithelial markers. These studies indicate that WT1 expression can initiate features of a program of epithelial differentiation consistent with a prominent role for WT1 in the mesenchymal epithelial transition that occurs during renal development. Through this work we identified a number of novel target genes for the WT1 transcription factor, including uvomorulin, integrin alpha8 and perlecan, and suggest that WTI may activate the IGF-II gene, also implicated in the development of Wilms' tumor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927198     DOI: 10.1038/sj.onc.1202311

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Versican mediates mesenchymal-epithelial transition.

Authors:  Wang Sheng; Guizhi Wang; David P La Pierre; Jianping Wen; Zhaoqun Deng; Chung-Kwun Amy Wong; Daniel Y Lee; Burton B Yang
Journal:  Mol Biol Cell       Date:  2006-02-01       Impact factor: 4.138

2.  Noncytotoxic differentiation treatment of renal cell cancer.

Authors:  Soledad Negrotto; Zhenbo Hu; Oscar Alcazar; Kwok Peng Ng; Pierre Triozzi; Daniel Lindner; Brian Rini; Yogen Saunthararajah
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

Review 3.  WT1/EGR1-mediated control of STIM1 expression and function in cancer cells.

Authors:  Michael F Ritchie; Yandong Zhou; Jonathan Soboloff
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01

4.  Identification of cells responsible for urokinase-type plasminogen activator synthesis and secretion in human diploid kidney cell cultures.

Authors:  Safedin Beqaj; Anuja M Shah; Jon M Ryan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Mar-Apr       Impact factor: 2.416

5.  Serine threonine receptor-associated protein (STRAP) plays a role in the maintenance of mesenchymal morphology.

Authors:  Nilesh D Kashikar; Jennifer Reiner; Arunima Datta; Pran K Datta
Journal:  Cell Signal       Date:  2009-09-23       Impact factor: 4.315

6.  A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16.

Authors:  Marianne K-H Kim; Jacqueline M Mason; Chi-Ming Li; Windy Berkofsky-Fessler; Le Jiang; Divaker Choubey; Paul E Grundy; Benjamin Tycko; Jonathan D Licht
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

7.  Lack of α8 integrin leads to morphological changes in renal mesangial cells, but not in vascular smooth muscle cells.

Authors:  Ines Marek; Gudrun Volkert; Angelika Jahn; Fabian Fahlbusch; Christina Zürn; Zehra Ozcan; Margarete Goppelt-Struebe; Karl F Hilgers; Wolfgang Rascher; Andrea Hartner
Journal:  BMC Cell Biol       Date:  2010-12-31       Impact factor: 4.241

8.  A mutant Ahr allele protects the embryonic kidney from hydrocarbon-induced deficits in fetal programming.

Authors:  Adrian Nanez; Irma N Ramos; Kenneth S Ramos
Journal:  Environ Health Perspect       Date:  2011-07-29       Impact factor: 9.031

9.  N -Methyl- N -nitrosourea-induced Renal Tumors in Rats: Immunohistochemical Comparison to Human Wilms Tumors.

Authors:  Katsuhiko Yoshizawa; Yuichi Kinoshita; Yuko Emoto; Ayako Kimura; Norihisa Uehara; Takashi Yuri; Nobuaki Shikata; Airo Tsubura
Journal:  J Toxicol Pathol       Date:  2013-07-10       Impact factor: 1.628

10.  Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.

Authors:  Suraj Peri; Elena Caretti; Rossella Tricarico; Karthik Devarajan; Mitchell Cheung; Eleonora Sementino; Craig W Menges; Emmanuelle Nicolas; Lisa A Vanderveer; Sharon Howard; Peggy Conrad; James A Crowell; Kerry S Campbell; Eric A Ross; Andrew K Godwin; Anthony T Yeung; Margie L Clapper; Robert G Uzzo; Elizabeth P Henske; Christopher J Ricketts; Cathy D Vocke; W Marston Linehan; Joseph R Testa; Alfonso Bellacosa; Levy Kopelovich; Alfred G Knudson
Journal:  Oncotarget       Date:  2017-03-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.